Amyris Inc. completed its IPO on September 28, 2010 at $16 a share, raising $85 million with underwriters Morgan Stanley, J.P. Morgan and Goldman Sachs. Amyris listed its common stock on the Nasdaq under the symbol AMRS.
With 40.4 million shares outstanding after the IPO, Amyris went public with a market capitalization of about $650 million. Marquee investment firm Kleiner Perkins Caufield and Byers invested in Amyris, along with Khosla Ventures and TPG Biotechnology Partners, and French oil giant Total.
The company has had strong after market performance and as of 6/6/11, the company had a market capitalization of $1.3 Billion.
